TW201318642A - Method for producing O/W emulsified composition - Google Patents
Method for producing O/W emulsified composition Download PDFInfo
- Publication number
- TW201318642A TW201318642A TW101135479A TW101135479A TW201318642A TW 201318642 A TW201318642 A TW 201318642A TW 101135479 A TW101135479 A TW 101135479A TW 101135479 A TW101135479 A TW 101135479A TW 201318642 A TW201318642 A TW 201318642A
- Authority
- TW
- Taiwan
- Prior art keywords
- emulsified
- aqueous phase
- oxygen
- emulsified composition
- mass
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 96
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 25
- 239000008346 aqueous phase Substances 0.000 claims abstract description 73
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 49
- 239000003945 anionic surfactant Substances 0.000 claims abstract description 42
- 239000012071 phase Substances 0.000 claims abstract description 37
- 125000002947 alkylene group Chemical group 0.000 claims abstract description 35
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims abstract description 27
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 24
- 238000001816 cooling Methods 0.000 claims abstract description 21
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 19
- 239000000839 emulsion Substances 0.000 claims abstract description 15
- 238000003756 stirring Methods 0.000 claims abstract description 11
- 239000001301 oxygen Substances 0.000 claims description 16
- 229910052760 oxygen Inorganic materials 0.000 claims description 16
- 125000000217 alkyl group Chemical group 0.000 claims description 14
- 125000004432 carbon atom Chemical group C* 0.000 claims description 14
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 14
- 238000004945 emulsification Methods 0.000 claims description 9
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 7
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 5
- 229930195712 glutamate Natural products 0.000 claims description 3
- 239000004094 surface-active agent Substances 0.000 claims description 3
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 150000001450 anions Chemical class 0.000 claims 1
- 230000001568 sexual effect Effects 0.000 claims 1
- 239000002245 particle Substances 0.000 abstract description 33
- 238000000034 method Methods 0.000 abstract description 21
- 238000002156 mixing Methods 0.000 abstract description 8
- 230000001804 emulsifying effect Effects 0.000 abstract description 2
- 239000003921 oil Substances 0.000 description 45
- 235000019198 oils Nutrition 0.000 description 45
- -1 arachyl alcohol Chemical compound 0.000 description 25
- 239000000499 gel Substances 0.000 description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 14
- 235000014113 dietary fatty acids Nutrition 0.000 description 11
- 239000000194 fatty acid Substances 0.000 description 11
- 229930195729 fatty acid Natural products 0.000 description 11
- 150000004665 fatty acids Chemical class 0.000 description 11
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 10
- 239000003814 drug Substances 0.000 description 10
- 239000004615 ingredient Substances 0.000 description 10
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 8
- 239000002537 cosmetic Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 239000011734 sodium Substances 0.000 description 8
- 229910052708 sodium Inorganic materials 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 230000007613 environmental effect Effects 0.000 description 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 229940104261 taurate Drugs 0.000 description 6
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 6
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 6
- 239000006071 cream Substances 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- GOQYKNQRPGWPLP-UHFFFAOYSA-N heptadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 4
- KPSSIOMAKSHJJG-UHFFFAOYSA-N neopentyl alcohol Chemical compound CC(C)(C)CO KPSSIOMAKSHJJG-UHFFFAOYSA-N 0.000 description 4
- 229930182490 saponin Natural products 0.000 description 4
- 150000007949 saponins Chemical class 0.000 description 4
- 235000017709 saponins Nutrition 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 239000003125 aqueous solvent Substances 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- SHZIWNPUGXLXDT-UHFFFAOYSA-N caproic acid ethyl ester Natural products CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 238000000113 differential scanning calorimetry Methods 0.000 description 3
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 230000006641 stabilisation Effects 0.000 description 3
- 238000011105 stabilization Methods 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 2
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 2
- 235000009685 Crataegus X maligna Nutrition 0.000 description 2
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 2
- 235000009486 Crataegus bullatus Nutrition 0.000 description 2
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 2
- 235000009682 Crataegus limnophila Nutrition 0.000 description 2
- 240000000171 Crataegus monogyna Species 0.000 description 2
- 235000004423 Crataegus monogyna Nutrition 0.000 description 2
- 235000002313 Crataegus paludosa Nutrition 0.000 description 2
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- 244000280244 Luffa acutangula Species 0.000 description 2
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- DMLHPCALHMPJHS-UHFFFAOYSA-N Nepodin Chemical compound C1=CC=C(O)C2=C(O)C(C(=O)C)=C(C)C=C21 DMLHPCALHMPJHS-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 235000005247 Rumex japonicus Nutrition 0.000 description 2
- 244000189123 Rumex japonicus Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 150000001342 alkaline earth metals Chemical class 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 2
- 229960000735 docosanol Drugs 0.000 description 2
- 239000010696 ester oil Substances 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 229940049906 glutamate Drugs 0.000 description 2
- 229960002989 glutamic acid Drugs 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- IRHTZOCLLONTOC-UHFFFAOYSA-N hexacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCO IRHTZOCLLONTOC-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002120 nanofilm Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- REIUXOLGHVXAEO-UHFFFAOYSA-N pentadecan-1-ol Chemical compound CCCCCCCCCCCCCCCO REIUXOLGHVXAEO-UHFFFAOYSA-N 0.000 description 2
- 229920002098 polyfluorene Polymers 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- 229940104256 sodium taurate Drugs 0.000 description 2
- GWLWWNLFFNJPDP-UHFFFAOYSA-M sodium;2-aminoethanesulfonate Chemical compound [Na+].NCCS([O-])(=O)=O GWLWWNLFFNJPDP-UHFFFAOYSA-M 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 150000003573 thiols Chemical class 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- UMBHVAZDOAKHJC-HVDRVSQOSA-N (2S)-2-aminopentanedioic acid dodecanoic acid Chemical compound N[C@@H](CCC(O)=O)C(O)=O.CCCCCCCCCCCC(O)=O UMBHVAZDOAKHJC-HVDRVSQOSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- URZGHMFEWPZZTF-VAGRMJETSA-N (2s)-2-aminobutanedioic acid;2-[bis(2-hydroxyethyl)amino]ethanol Chemical compound OC(=O)[C@@H](N)CC(O)=O.OCCN(CCO)CCO.OCCN(CCO)CCO URZGHMFEWPZZTF-VAGRMJETSA-N 0.000 description 1
- FLTMPBPKBJLSBA-VKHMYHEASA-N (4S)-4-amino-5-oxo-5-sulfanyloxypentanoic acid Chemical compound C(CC(=O)O)[C@@H](C(=O)OS)N FLTMPBPKBJLSBA-VKHMYHEASA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- XFRVVPUIAFSTFO-UHFFFAOYSA-N 1-Tridecanol Chemical compound CCCCCCCCCCCCCO XFRVVPUIAFSTFO-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- WLRWTEIAYJHXDW-UHFFFAOYSA-N 2,2,3,3,4,4,4a,5,5,6-decamethyl-6H-cyclopenta[b]pyran Chemical compound CC1C=C2C(C(C(C(O2)(C)C)(C)C)(C)C)(C1(C)C)C WLRWTEIAYJHXDW-UHFFFAOYSA-N 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 1
- AYUKNFXLSTVUAB-UHFFFAOYSA-N 2-[2-[2-(2,2-dimethylpropanoyloxy)propoxy]propoxy]propyl 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OC(C)COC(C)COC(C)COC(=O)C(C)(C)C AYUKNFXLSTVUAB-UHFFFAOYSA-N 0.000 description 1
- BDOYKFSQFYNPKF-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;sodium Chemical compound [Na].[Na].OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O BDOYKFSQFYNPKF-UHFFFAOYSA-N 0.000 description 1
- BTMZHHCFEOXAAN-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanol;2-dodecylbenzenesulfonic acid Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCC1=CC=CC=C1S(O)(=O)=O BTMZHHCFEOXAAN-UHFFFAOYSA-N 0.000 description 1
- NZAKDNQAIWGNOG-UHFFFAOYSA-N 2-benzylpyridine-3-carboxylic acid Chemical compound OC(=O)C1=CC=CN=C1CC1=CC=CC=C1 NZAKDNQAIWGNOG-UHFFFAOYSA-N 0.000 description 1
- WBIQQQGBSDOWNP-UHFFFAOYSA-N 2-dodecylbenzenesulfonic acid Chemical compound CCCCCCCCCCCCC1=CC=CC=C1S(O)(=O)=O WBIQQQGBSDOWNP-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 240000008075 Achillea alpina Species 0.000 description 1
- 241000157282 Aesculus Species 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000086254 Arnica montana Species 0.000 description 1
- 235000017519 Artemisia princeps Nutrition 0.000 description 1
- 244000065027 Artemisia princeps Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 1
- 240000001548 Camellia japonica Species 0.000 description 1
- 235000006467 Camellia japonica Nutrition 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- VQAWRQZAAIQXHM-UHFFFAOYSA-N Cepharanthine Natural products O1C(C=C2)=CC=C2CC(C=23)N(C)CCC3=CC=3OCOC=3C=2OC(=CC=23)C(OC)=CC=2CCN(C)C3CC2=CC=C(O)C1=C2 VQAWRQZAAIQXHM-UHFFFAOYSA-N 0.000 description 1
- 241000422842 Chamaecyparis pisifera Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 1
- 235000001950 Elaeis guineensis Nutrition 0.000 description 1
- 244000127993 Elaeis melanococca Species 0.000 description 1
- 241000195950 Equisetum arvense Species 0.000 description 1
- 239000005768 Equisetum arvense L. Substances 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 240000002624 Mespilus germanica Species 0.000 description 1
- 235000017784 Mespilus germanica Nutrition 0.000 description 1
- 235000000560 Mimusops elengi Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- QZXSMBBFBXPQHI-UHFFFAOYSA-N N-(dodecanoyl)ethanolamine Chemical compound CCCCCCCCCCCC(=O)NCCO QZXSMBBFBXPQHI-UHFFFAOYSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 244000108404 Nuphar japonicum Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 1
- RVSTWRHIGKXTLG-UHFFFAOYSA-N Pangamic acid Natural products CC(C)N(C(C)C)C(N(C(C)C)C(C)C)C(=O)OCC(O)C(O)C(O)C(O)C(O)=O RVSTWRHIGKXTLG-UHFFFAOYSA-N 0.000 description 1
- DJWYOLJPSHDSAL-UHFFFAOYSA-N Pantethine Natural products OCC(C)(C)C(O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)C(O)C(C)(C)CO DJWYOLJPSHDSAL-UHFFFAOYSA-N 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 235000007685 Pleurotus columbinus Nutrition 0.000 description 1
- 240000001462 Pleurotus ostreatus Species 0.000 description 1
- 235000001603 Pleurotus ostreatus Nutrition 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- YETPYDGBYCOUAW-UHFFFAOYSA-N SNC(N(CC(=O)O)C)=N Chemical compound SNC(N(CC(=O)O)C)=N YETPYDGBYCOUAW-UHFFFAOYSA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- KYWSCMDFVARMPN-LCSVLAELSA-N Saikosaponin D Chemical compound O([C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@]([C@H]3[C@]([C@@H]4[C@@]([C@@]5(C[C@@H](O)[C@]67CO[C@]5([C@@H]6CC(C)(C)CC7)C=C4)C)(C)CC3)(C)CC2)(C)CO)O[C@@H]([C@@H]1O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O KYWSCMDFVARMPN-LCSVLAELSA-N 0.000 description 1
- 241000580938 Sapindus Species 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 241001647091 Saxifraga granulata Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 241000246044 Sophora flavescens Species 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 241000967294 Swertia japonica Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- 235000007837 Vangueria infausta Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- CMPDPBDUZTUXAD-UHFFFAOYSA-N [3-hydroxy-2-(16-methylheptadecanoyloxy)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCC(C)C CMPDPBDUZTUXAD-UHFFFAOYSA-N 0.000 description 1
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 1
- RSWNFFQQMFAPLI-FGJQBABTSA-N [Na].[Na].C(CCCCCCCCCCCCCCCCC)N[C@@H](CCC(=O)O)C(=O)O Chemical compound [Na].[Na].C(CCCCCCCCCCCCCCCCC)N[C@@H](CCC(=O)O)C(=O)O RSWNFFQQMFAPLI-FGJQBABTSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000012644 addition polymerization Methods 0.000 description 1
- 230000003679 aging effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 125000003289 ascorbyl group Chemical group [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- 229940071097 ascorbyl phosphate Drugs 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- YVPXVXANRNDGTA-WDYNHAJCSA-N cepharanthine Chemical compound C1C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@H](C2=C3)N(C)CCC2=CC(OC)=C3OC2=C(OCO3)C3=CC3=C2[C@H]1N(C)CC3 YVPXVXANRNDGTA-WDYNHAJCSA-N 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- UCULDQVXOYLVHV-UHFFFAOYSA-N decan-1-amine;ethanol Chemical compound CCO.CCCCCCCCCCN UCULDQVXOYLVHV-UHFFFAOYSA-N 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 238000006471 dimerization reaction Methods 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- KBNXJNVJRYRDNG-UHFFFAOYSA-N dodecyl 2-hydroxyethanesulfonate Chemical compound CCCCCCCCCCCCOS(=O)(=O)CCO KBNXJNVJRYRDNG-UHFFFAOYSA-N 0.000 description 1
- YRIUSKIDOIARQF-UHFFFAOYSA-N dodecyl benzenesulfonate Chemical compound CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 YRIUSKIDOIARQF-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940071161 dodecylbenzenesulfonate Drugs 0.000 description 1
- 229940060296 dodecylbenzenesulfonic acid Drugs 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 229940035423 ethyl ether Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229940043351 ethyl-p-hydroxybenzoate Drugs 0.000 description 1
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 229940116364 hard fat Drugs 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000010181 horse chestnut Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- XGFDHKJUZCCPKQ-UHFFFAOYSA-N n-nonadecyl alcohol Natural products CCCCCCCCCCCCCCCCCCCO XGFDHKJUZCCPKQ-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- RKLWETFPHFCMOO-UHFFFAOYSA-N octadecyl 2-hydroxyethanesulfonate Chemical compound CCCCCCCCCCCCCCCCCCOS(=O)(=O)CCO RKLWETFPHFCMOO-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-MDZDMXLPSA-N oleyl alcohol Chemical compound CCCCCCCC\C=C\CCCCCCCCO ALSTYHKOOCGGFT-MDZDMXLPSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 125000005702 oxyalkylene group Chemical group 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- ZQTHOIGMSJMBLM-BUJSFMDZSA-N pangamic acid Chemical compound CN(C)CC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O ZQTHOIGMSJMBLM-BUJSFMDZSA-N 0.000 description 1
- 108700024047 pangamic acid Proteins 0.000 description 1
- DJWYOLJPSHDSAL-ROUUACIJSA-N pantethine Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO DJWYOLJPSHDSAL-ROUUACIJSA-N 0.000 description 1
- 235000008975 pantethine Nutrition 0.000 description 1
- 239000011581 pantethine Substances 0.000 description 1
- 229960000903 pantethine Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 229940056211 paraffin Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- 235000008729 phenylalanine Nutrition 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- 229940116985 potassium lauryl sulfate Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 229930192014 saikosaponin Natural products 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 229940045885 sodium lauroyl sarcosinate Drugs 0.000 description 1
- 229940079862 sodium lauryl sarcosinate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 229940074404 sodium succinate Drugs 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- ADWNFGORSPBALY-UHFFFAOYSA-M sodium;2-[dodecyl(methyl)amino]acetate Chemical compound [Na+].CCCCCCCCCCCCN(C)CC([O-])=O ADWNFGORSPBALY-UHFFFAOYSA-M 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- 229940093609 tricaprylin Drugs 0.000 description 1
- 229940087291 tridecyl alcohol Drugs 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
- 235000002374 tyrosine Nutrition 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
- C09K23/017—Mixtures of compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
- C09K23/02—Alkyl sulfonates or sulfuric acid ester salts derived from monohydric alcohols
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
- C09K23/28—Aminocarboxylic acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Materials Engineering (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
本案係主張於2011年10月24日申請之日本國發明專利申請案2011-232643號及於2011年11月1日申請之日本國發明專利申請案2011-239954號的優先權,並引用於此。 The priority of Japanese Patent Application No. 2011-232643 filed on Oct. 24, 2011, and Japanese Patent Application No. 2011-239954, filed on Nov. 1, 2011, is hereby incorporated by reference. .
本發明係關於O/W乳化組成物之製造方法,特別是關於可以簡便性、經濟性、環境適應性優異的方法製造乳化粒徑微細的O/W乳化組成物之方法,該O/W乳化組成物係使用在水中形成α膠(α-gel)的陰離子性界面活性劑與高級脂肪族醇。 The present invention relates to a method for producing an O/W emulsified composition, and more particularly to a method for producing an O/W emulsified composition having a fine emulsified particle diameter by a method which is excellent in simplicity, economy, and environmental compatibility, and the O/W emulsification The composition uses an anionic surfactant which forms α-gel in water and a higher aliphatic alcohol.
以往,採用由高級醇與陰離子性界面活性劑在水中所形成之α膠的O/W乳化組成物,係被使用在化妝料或醫藥品、準藥品等外用組成物(專利文獻1至4)。 In the past, an O/W emulsified composition using an alpha gel formed from a higher alcohol and an anionic surfactant in water was used as a cosmetic composition, a pharmaceutical composition, a quasi-drug, and the like (Patent Documents 1 to 4). .
就調製此種O/W乳化組成物之方法而言,以往通常是採用在溶解有陰離子性界面活性劑之80℃以上的水相中,加入溶解有高級脂肪族醇之80℃以上的油相,並經均質機等進行乳化,然後將其以Onlator等冷卻機冷卻至35℃左右為止之方法。就此種O/W乳化組成物而言,已溶解於高溫油滴之乳化粒子中之高級脂肪族醇係會隨著因冷卻所致之溫度降低而出現於乳化粒子表面,並與 存在於水中之陰離子性界面活性劑一起形成凝集體(α膠),而包圍住乳化粒子界面,有助於使O/W乳化組成物安定化(非專利文獻1)。 In the method of preparing such an O/W emulsified composition, an oil phase in which 80 ° C or higher in which a higher aliphatic alcohol is dissolved is added to an aqueous phase in which an anionic surfactant is dissolved at 80 ° C or higher is conventionally used. The mixture is emulsified by a homogenizer or the like, and then cooled to about 35 ° C by a cooler such as Onlator. In the case of such an O/W emulsified composition, the higher aliphatic alcohol which has been dissolved in the emulsified particles of the high-temperature oil droplets appears on the surface of the emulsified particles with a decrease in temperature due to cooling, and The anionic surfactant present in water forms an aggregate (α gel) together, and surrounds the interface of the emulsified particles, contributing to the stabilization of the O/W emulsified composition (Non-Patent Document 1).
然而,像以往如此於80℃以上進行乳化後再冷卻的方法,會因加熱成分或使用熱交換機,故需要能量,而造成較多無謂浪費。此外,Onlator等冷卻機在使用後之洗淨需使用多量的水,而使環境負擔變高。 However, as in the prior art, the method of emulsification after 80 ° C or more and then cooling is required to heat the components or use the heat exchanger, so that energy is required, resulting in more unnecessary waste. In addition, the cooling device such as Onlator requires a large amount of water to be washed after use, and the environmental burden is increased.
因此,正期望開發不需像以往般要加熱全部成分或使用Onlator等冷卻裝置,而可經濟且容易地製造O/W乳化組成物之方法。 Therefore, it is desired to develop a method which can economically and easily produce an O/W emulsified composition without heating all the components as in the past or using a cooling device such as an Onlator.
近年來,已有報告記載將包含非離子性界面活性劑、可與前述非離子性界面活性劑一起在水中形成α膠之直鏈狀高級醇、及油分的油相,和水相的一部分於70℃以上進行乳化,以調製高濃度的O/W乳化部分,並將該乳化部分一邊攪拌一邊與10至35℃之剩餘部分的水相進行混合,以製造O/W乳化組成物之方法(專利文獻5)。 In recent years, it has been reported that a non-ionic surfactant, a linear higher alcohol capable of forming an alpha gum in water together with the nonionic surfactant, and an oil phase of an oil component, and a part of an aqueous phase are described. Emulsification at 70 ° C or higher to prepare a high concentration O/W emulsified portion, and mixing the emulsified portion with an aqueous phase of the remaining portion of 10 to 35 ° C while stirring to produce an O/W emulsified composition ( Patent Document 5).
因為該方法不需加熱全部成分,且不使用Onlator等冷卻裝置即可製造O/W乳化組成物,故簡便性、經濟性、環境適應性優異。 Since this method does not require heating all the components and can produce an O/W emulsified composition without using a cooling device such as Onlator, it is excellent in simplicity, economy, and environmental suitability.
然而,專利文獻5並未檢討關於使用可在水中形成α膠之陰離子性界面活性劑與高級脂肪酸醇之情形。 However, Patent Document 5 does not review the case of using an anionic surfactant which can form an alpha gum in water and a higher fatty acid alcohol.
並且,本發明者等經檢討後,得知當使用可在水中形成α膠之陰離子性界面活性劑與高級脂肪族醇、油分、以及水相的一部分來調製高濃度的O/W乳化部分,並於該乳化部分中混合低溫的剩餘部分的水相且進行冷卻而欲得到O/W乳化組成物時,極難得 到乳化粒徑微細的O/W乳化組成物。 Further, after reviewing the present inventors, it has been found that when a part of an anionic surfactant which can form an alpha gel in water and a higher aliphatic alcohol, an oil component, and an aqueous phase are used to prepare a high concentration O/W emulsified portion, It is extremely rare to mix the water phase of the remaining portion of the low temperature in the emulsified portion and to cool it to obtain an O/W emulsified composition. To emulsify the O/W emulsified composition having a fine particle size.
[專利文獻1]日本特開2001-348325號公報 [Patent Document 1] Japanese Patent Laid-Open Publication No. 2001-348325
[專利文獻2]日本特開2005-132808號公報 [Patent Document 2] Japanese Patent Laid-Open Publication No. 2005-132808
[專利文獻3]日本特開2008-44866號公報 [Patent Document 3] Japanese Patent Laid-Open Publication No. 2008-44866
[專利文獻4]日本發明專利第4767352號公報 [Patent Document 4] Japanese Invention Patent No. 4767352
[專利文獻5]日本特開2011-74071號公報 [Patent Document 5] Japanese Patent Laid-Open Publication No. 2011-74071
[非專利文獻1]妹尾學著,「界面活性之化學與應用」,大日本圖書,1995年,p.159-160 [Non-Patent Document 1] Sister Tail, "Chemistry and Application of Interface Activity", Dainippon Books, 1995, p.159-160
本發明係有鑑於上述先前技術之情事而研創者,其目的係使用在水中形成α膠的陰離子性界面活性劑與高級脂肪族醇,以簡便性、經濟性、環境適應性優異的方法提供具有微細的乳化粒徑之O/W乳化組成物。 The present invention has been made in view of the above-mentioned prior art, and an object thereof is to provide an anionic surfactant and a higher aliphatic alcohol which form an alpha gel in water, and are provided by a method excellent in simplicity, economy, and environmental adaptability. A finely emulsified particle size O/W emulsified composition.
本發明者等經檢討後,結果發現當使用可在水中形成α膠之陰離子性界面活性劑與高級脂肪族醇、油分、以及水相的一部分而調製高濃度的O/W乳化部分時,若使用特定量的伸烷基氧化物(alkylene oxide)衍生物,且於該乳化部分中混合低溫之剩餘部分的水相,並進行冷卻而調製O/W乳化組成物,則會得到乳化粒徑微細的O/W乳化組成物,遂完成本發明。 The inventors of the present invention have found that when a high-concentration O/W emulsified portion is prepared by using an anionic surfactant capable of forming an alpha gel in water, a higher aliphatic alcohol, an oil component, and a part of an aqueous phase, A specific amount of an alkylene oxide derivative is used, and an aqueous phase of the remaining portion of the low temperature is mixed in the emulsified portion, and the O/W emulsified composition is prepared by cooling to obtain a fine emulsified particle size. The O/W emulsified composition, 遂 completed the present invention.
亦即,本發明之O/W乳化組成物之製造方法係包括下述步驟:將包含下述(A)與(B)之油相、和包含下述(C)與(D)與(E)之水相的一部分(第1水相),於80℃以上之溫度進行乳化而調製O/W乳化部分的步驟:(A)碳數12至26之高級脂肪族醇、(B)油分、(C)可與前述(A)在水中形成並獲得α膠之陰離子性界面活性劑、(D)下述通式(1)所示之伸烷基氧化物衍生物、(E)水;以及藉由將前述乳化部分與10至35℃之殘餘之水相(第2水相)一邊攪拌一邊混合而進行冷卻之步驟;其中,前述(D)伸烷基氧化物衍生物為前述乳化部分中的1至30質量%。 That is, the method for producing the O/W emulsified composition of the present invention comprises the steps of: containing the oil phases of the following (A) and (B), and comprising the following (C) and (D) and (E) a part of the aqueous phase (first aqueous phase), which is emulsified at a temperature of 80 ° C or higher to prepare an O/W emulsified portion: (A) a higher aliphatic alcohol having a carbon number of 12 to 26, (B) an oil component, (C) an anionic surfactant which can be formed in the above (A) in water and obtains α gel, (D) an alkylene oxide derivative represented by the following formula (1), and (E) water; a step of cooling by mixing the emulsified portion with a residual aqueous phase (second aqueous phase) of 10 to 35 ° C while stirring; wherein the (D) alkylene oxide derivative is in the aforementioned emulsified portion 1 to 30% by mass.
R1O-[(AO)m(EO)n]-R2 (1)(式中,AO為碳數3至4之氧伸烷基(oxyalkylene),EO為氧伸乙基(oxyethylene);m及n分別為前述氧伸烷基、氧伸乙基之平均加成莫耳數,且1≦m≦70,1≦n≦70。相對於碳數3至4之氧伸烷基與氧伸乙基之合計,氧伸烷基之比率為20至80重量%。碳數3至4之氧伸烷基與氧伸乙基可為嵌段狀加成,亦可為無規狀加成。R1、R2係可為相同或相異之碳數1至4的烷基。) R 1 O—[(AO) m (EO) n ]-R 2 (1) (wherein AO is an oxyalkylene having a carbon number of 3 to 4, and EO is an oxyethylene group; m and n are the average addition molar number of the above oxygen alkyl group and oxygen extension ethyl group, and 1 ≦ m ≦ 70, 1 ≦ n ≦ 70. The alkyl group and oxygen are 3 to 4 carbon atoms. The total of the ethyl groups, the ratio of the oxygen alkyl group is 20 to 80% by weight, the oxygen alkyl group having 3 to 4 carbon atoms and the oxygen stretching ethyl group may be a block addition or a random addition. The R 1 and R 2 groups may be the same or different alkyl groups having 1 to 4 carbon atoms.)
此外,本發明係提供一種O/W乳化組成物之製造方法,其特徵係在前述方法中,(C)陰離子性界面活性劑為選自N-醯基磺酸鹽型陰離子性界面活性劑及N-醯基麩胺酸鹽型陰離子性界面活性劑。 Furthermore, the present invention provides a method for producing an O/W emulsified composition, characterized in that (C) an anionic surfactant is an anionic surfactant selected from the group consisting of N-mercapto sulfonate type and N-mercapto glutamate type anionic surfactant.
此外,本發明係提供一種O/W乳化組成物之製造方法,其特徵係在前述記載之任一方法中,O/W乳化組成物總量中之前述第2水相為40至75質量%。 Furthermore, the present invention provides a method for producing an O/W emulsified composition, characterized in that in any one of the above methods, the second aqueous phase in the total amount of the O/W emulsified composition is 40 to 75% by mass. .
此外,本發明係提供一種O/W乳化組成物之製造方法,其特徵係在前述記載之任一方法中,相對於(B)油分10質量份,(A)碳數12至26之高級脂肪族醇與(C)陰離子性界面活性劑之合計量為0.5至10質量份。 Further, the present invention provides a method for producing an O/W emulsified composition, characterized in that, in any of the above-described methods, (A) a fat having a carbon number of 12 to 26 with respect to (B) an oil component of 10 parts by mass. The total amount of the alcohol and the (C) anionic surfactant is 0.5 to 10 parts by mass.
依據本發明之方法,不需加熱作為目的之O/W乳化組成物的全部成分,且亦不需使用Onlator等冷卻裝置而即可製造O/W乳化組成物,故簡便性、經濟性、環境適應性優異。而且,藉由在調製乳化部分之第1水相中包含特定量之伸烷基氧化物衍生物,即可容易地得到乳化粒徑微細的O/W乳化組成物。 According to the method of the present invention, it is not necessary to heat all the components of the intended O/W emulsified composition, and the O/W emulsified composition can be produced without using a cooling device such as Onlator, so that the simplicity, economy, and environment Excellent adaptability. Further, by including a specific amount of the alkylene oxide derivative in the first aqueous phase of the emulsified portion, an O/W emulsified composition having a fine emulsified particle diameter can be easily obtained.
本發明之O/W乳化組成物之製造方法,其特徵係於使油相乳化於水相中而成之O/W乳化組成物之製造方法中,包含後述第1步驟及第2步驟。 The method for producing an O/W emulsified composition of the present invention is characterized in that the method for producing an O/W emulsified composition obtained by emulsifying an oil phase in an aqueous phase comprises a first step and a second step which will be described later.
將油相、水相的一部分(第1水相)於80℃以上的溫度進行乳化而調製O/W乳化部分的步驟。 The oil phase and a part of the aqueous phase (the first aqueous phase) are emulsified at a temperature of 80 ° C or higher to prepare an O/W emulsified portion.
藉由將前述乳化部分與10至35℃之剩餘部分的水相(第2水 相)一邊攪拌一邊混合而進行冷卻之步驟。 By the aqueous phase of the aforementioned emulsified portion with the remainder of 10 to 35 ° C (2nd water) The step of mixing while stirring is carried out.
前述油相係包含:(A)碳數12至26之高級脂肪族醇、及(B)油分。 The oil phase system includes: (A) a higher aliphatic alcohol having a carbon number of 12 to 26, and (B) an oil component.
前述第1水相係包含:(C)與前述(A)在水中形成並獲得α膠的陰離子性界面活性劑、(D)伸烷基氧化物衍生物、及(E)水。 The first aqueous phase includes (C) an anionic surfactant which is formed in water (A) and obtains an α gel, (D) an alkylene oxide derivative, and (E) water.
此外,在本發明之方法中,前述乳化部分中係包含前述(D)伸烷基氧化物衍生物1至30質量%、較佳為包含3至25質量%。 Further, in the method of the present invention, the emulsified portion contains the (D) alkylene oxide derivative in an amount of from 1 to 30% by mass, preferably from 3 to 25% by mass.
如此所得之O/W乳化組成物的乳化粒子界面係形成有α膠。α膠,係指在與水共存之狀態下,界面活性劑與高級醇一同形成之包含片狀(lamellar)2分子膜的凝集體。 The emulsified particle interface of the O/W emulsified composition thus obtained was formed with an α gel. The α-gel refers to an aggregate comprising a lamellar 2 molecular film formed by a surfactant together with a higher alcohol in a state of coexistence with water.
以往,是藉由將包含(A)高級脂肪族醇之油相及包含(C)可與前述(A)在水中形成並獲得α膠的陰離子性界面活性劑之水相於80℃以上之溫度進行乳化並將其冷卻的步驟而得到O/W乳化組成物,惟會因加熱和使用熱交換機而導致能量浪費較多,且若使用Onlator等冷卻裝置則會有導致造成經濟上/環境上的負擔之問題。 In the past, an oil phase containing (A) a higher aliphatic alcohol and an aqueous phase containing (C) an anionic surfactant which can be formed in the above (A) in water and obtained an alpha gel are at a temperature of 80 ° C or higher. The step of emulsification and cooling is carried out to obtain an O/W emulsified composition, but energy is wasted due to heating and use of a heat exchanger, and if a cooling device such as Onlator is used, it may cause economic/environmental The problem of burden.
相對於此,本發明中,係使用作為目的之O/W乳化組成物之水相成分的一部分(第1水相)與油相成分而於80℃以上(較佳為80至85℃)調製以高濃度乳化而成之O/W乳化部分,並將上述乳化部分與10至35℃之低溫的殘餘水相成分(第2水相)一邊攪拌一邊徐緩地混合。藉此,使高溫乳化部分被稀釋且同時被冷卻,而使高溫乳化部分之乳化粒子中所溶解的高級脂肪族醇出現,於乳化粒子界面與陰離子性界面活性劑及水一同形成α膠,而得到O/W乳化組成物。又,乳化溫度若未達80℃,則會有乳化部分不溶解之情形。用於乳化、攪拌等之裝置,只要從通常所使用者中適宜 選擇即可,可直接利用以往所使用之裝置,不需特別的設備。乳化部分與第2水相之混合順序係無特別限制。 On the other hand, in the present invention, a part (first aqueous phase) of the aqueous phase component of the target O/W emulsified composition and an oil phase component are used to prepare at 80 ° C or higher (preferably 80 to 85 ° C). The O/W emulsified portion which was emulsified at a high concentration was slowly mixed with the emulsified portion and a residual aqueous phase component (second aqueous phase) at a low temperature of 10 to 35 ° C while stirring. Thereby, the high-temperature emulsified portion is diluted and simultaneously cooled, and the higher aliphatic alcohol dissolved in the emulsified particles of the high-temperature emulsified portion appears, and the α-glue is formed together with the anionic surfactant and water at the interface of the emulsified particles. An O/W emulsified composition was obtained. Further, if the emulsification temperature is less than 80 ° C, the emulsified portion may not be dissolved. For emulsification, agitation, etc., as long as it is suitable for the general user You can choose to use the equipment you used in the past without special equipment. The order of mixing the emulsified portion and the second aqueous phase is not particularly limited.
因此,若依據本發明之製造方法,由於在乳化時不需使用Onlator等冷卻機,亦不需加熱多量之水相,故可以低能量容易地製造O/W乳化組成物。 Therefore, according to the production method of the present invention, since it is not necessary to use a cooling device such as an Onlator during emulsification, it is not necessary to heat a large amount of the aqueous phase, so that the O/W emulsified composition can be easily produced with low energy.
而且,本發明中,藉由使乳化部分中的(D)伸烷基氧化物衍生物為1至30質量%、較佳為3至25質量%,即可使所得之O/W乳化組成物的乳化粒徑成為10μm以下,進一步可微細化至5μm以下。乳化部分中的伸烷基氧化物衍生物無論是過少或過多,皆會無法得到乳化粒徑微細的O/W乳化組成物。此外,若使用其他的水性溶媒取代伸烷基氧化物衍生物,亦無法得到微細的O/W乳化組成物。 Further, in the present invention, the obtained O/W emulsified composition can be obtained by making the (D) alkyl oxide derivative in the emulsified portion 1 to 30% by mass, preferably 3 to 25% by mass. The emulsified particle diameter is 10 μm or less, and can be further reduced to 5 μm or less. Whether the alkylene oxide derivative in the emulsified portion is too small or too large, an O/W emulsified composition having a fine emulsified particle diameter cannot be obtained. Further, if another aqueous solvent is used instead of the alkylene oxide derivative, a fine O/W emulsified composition cannot be obtained.
如以上所述,本發明之O/W乳化組成物之製造方法,係僅藉由對使用特定量的伸烷基氧化物衍生物預先於80℃以上製造之高濃度之O/W乳化部分添加10至35℃之剩餘部分的水相,即可得到乳化粒徑微細的O/W乳化組成物,因此,可大幅地簡化以往所用的製造步驟,於經濟性、環境適應性方面亦優異。 As described above, the O/W emulsified composition of the present invention is produced by merely adding a high concentration O/W emulsified portion previously prepared at 80 ° C or higher using a specific amount of alkylene oxide derivative. The O/W emulsified composition having a fine emulsified particle diameter can be obtained by the aqueous phase of the remaining portion of 10 to 35 ° C. Therefore, the conventional production steps can be greatly simplified, and the economical and environmental compatibility are also excellent.
以下,說明本發明所使用的成分。 Hereinafter, the components used in the present invention will be described.
本發明中,(A)成分之碳數12至26之高級脂肪族醇,係與後述(C)成分之陰離子性界面活性劑於水中形成α膠的成分。 In the present invention, the higher aliphatic alcohol having a carbon number of 12 to 26 in the component (A) is a component which forms an α-gel in water with an anionic surfactant of the component (C) described later.
又,在水中形成α膠一事,係可藉由DSC(示差掃描熱析法;Differential Scanning Calorimetry)進行確認。亦即,相較於分別單獨將高級脂肪族醇與陰離子性界面活性劑溶解或分散於水而成之 試料所得之吸熱峰,將形成α膠之高級脂肪族醇和陰離子性界面活性劑一起與水混合所得之試料的吸熱峰係在更高溫側表示單一的峰,故可確認α膠之形成。 Further, the formation of α-gel in water can be confirmed by DSC (Differential Scanning Calorimetry). That is, the higher aliphatic alcohol and the anionic surfactant are separately dissolved or dispersed in water. In the endothermic peak obtained by the sample, the endothermic peak of the sample obtained by mixing the high-grade aliphatic alcohol and the anionic surfactant together with water to form a single peak on the higher temperature side, so that the formation of the α gel can be confirmed.
本發明所使用之高級脂肪族醇,可列舉一般使用於化妝品、醫藥品、準藥品等外用組成物者。例如,飽和直鏈一元醇可列舉如十二醇(=月桂醇)、十三醇、十四醇(=肉豆蔻醇)、十五醇、十六醇(=鯨蠟醇)、十七醇、十八醇(=硬脂醇)、十九醇、二十醇(=花生醇(arachyl alcohol))、二十一醇、二十二醇(=山萮醇)、二十三醇、二十四醇(=巴西棕櫚醇(carnaubyl alcohol))、二十五醇、二十六醇(=蠟醇(ceryl alcohol))等。不飽和一元醇可列舉如反-9-十八烯醇(elaidyl alcohol)等。就經時安定性之觀點來看,係以碳數12至26(較佳為碳數18至22)之飽和直鏈一元醇為較佳。 The higher aliphatic alcohol to be used in the present invention includes those generally used for external compositions such as cosmetics, pharmaceuticals, and quasi-drugs. For example, a saturated linear monohydric alcohol may, for example, be dodecyl alcohol (= lauryl alcohol), tridecyl alcohol, tetradecanol (=myristyl alcohol), pentadecyl alcohol, cetyl alcohol (=cephthyl alcohol), heptadecyl alcohol , octadecyl alcohol (=stearyl alcohol), nonadecanol, pentaerythritol (=arachyl alcohol), twenty-one alcohol, twenty-diol (= behenyl alcohol), twenty-three alcohol, two Tetradecanol (= carnaubyl alcohol), barcoal alcohol, hexadecanol (= ceryl alcohol), and the like. Examples of the unsaturated monohydric alcohol include, for example, elaidyl alcohol. From the standpoint of stability over time, a saturated linear monohydric alcohol having a carbon number of 12 to 26 (preferably having a carbon number of 18 to 22) is preferred.
(A)高級脂肪族醇係可使用1種或2種以上,較佳為使用2種以上之高級脂肪族醇的混合物。就O/W乳化組成物的溫度安定性之觀點來看,以其混合物的熔點成為60℃以上之組合為更佳。適當之組合的一例可列舉硬脂醇與山萮醇之組合。 (A) The higher aliphatic alcohol may be used singly or in combination of two or more kinds, and it is preferred to use a mixture of two or more kinds of higher aliphatic alcohols. From the viewpoint of temperature stability of the O/W emulsified composition, a combination in which the melting point of the mixture is 60 ° C or higher is more preferable. An example of a suitable combination is a combination of stearyl alcohol and behenyl alcohol.
(A)高級脂肪族醇係期望是以碳數算術平均所得到之平均碳數為18以上者。平均碳數未達18時,O/W乳化組成物的熔點變低,會有高溫安定性不充分之情形。又,平均碳數之上限值雖無特別限定,惟較佳為碳數係22左右。 (A) The higher aliphatic alcohol is desirably 18 or more in terms of an average carbon number obtained by arithmetical average of carbon numbers. When the average carbon number is less than 18, the melting point of the O/W emulsified composition becomes low, and the high temperature stability may be insufficient. Further, the upper limit of the average carbon number is not particularly limited, but it is preferably about 22 carbon atoms.
本發明中,通常,在O/W乳化組成物總量中,(A)高級脂肪族醇的調配量係0.05至10質量%,較佳為0.1至6質量%。 In the present invention, usually, the amount of the (A) higher aliphatic alcohol is from 0.05 to 10% by mass, preferably from 0.1 to 6% by mass, based on the total amount of the O/W emulsified composition.
本發明所使用之油分係無特別限定,適合使用一般使用於化 妝品、醫藥品、準藥品等外用組成物者。較佳係例如烴油、酯油等極性油、聚矽氧油(silicone oil)、液體油脂等,但並不限定於該等。 The oil system used in the present invention is not particularly limited, and is generally used for general use. For external use such as cosmetics, pharmaceuticals, and quasi-drugs. Preferred are, for example, polar oils such as hydrocarbon oils and ester oils, silicone oils, liquid fats and the like, but are not limited thereto.
烴油可列舉液體石蠟(liquid paraffin)、角鯊烷、角鯊烯、石蠟、異石蠟、白地蠟(ceresin)等。 The hydrocarbon oil may, for example, be liquid paraffin, squalane, squalene, paraffin, isoparaffin, ceresin or the like.
聚矽氧油可例示例如:二甲基聚矽氧烷(dimethylpolysiloxane)、甲基苯基聚矽氧烷、甲基氫聚矽氧烷等鏈狀聚矽氧;八甲基環四矽氧烷、十甲基環五矽氧烷、十二甲基環六矽氧烷等環狀聚矽氧;形成3次元網目構造之聚矽氧樹脂、聚矽氧橡膠等。 The polyoxyxene oil can be exemplified by a chain polyphosphonium such as dimethylpolysiloxane, methylphenyl polyoxyalkylene or methylhydrogenpolyoxane; octamethylcyclotetraoxane a cyclic polyfluorene oxide such as decamethylcyclopentaoxane or dodecamethylcyclohexaoxane; a polyfluorene oxide resin or a polyoxyxene rubber having a three-dimensional mesh structure.
酯油等極性油可列舉新戊四醇四乙基己酸酯、乙基己酸鯨蠟酯、荷荷芭油、月桂醯基麩胺酸二(植固醇/辛基十二基)酯、三異硬脂酸甘油酯(triisostearin)、二異硬脂酸甘油酯、三(乙基己酸)甘油酯(triethylhexanoin)、二聚亞油酸(植固醇/山萮)酯、二聚亞油酸(植固醇/異硬脂/鯨蠟/硬脂/山萮)酯、軟脂酸異丙酯、植固醇夏威夷豆脂肪酸酯(phytosteryl macadamiate)、新戊四醇四(山萮酸/安息香酸/乙基己酸)酯、軟脂酸乙基己酯、肉豆蔻酸肉豆蔻酯、三丙二醇二(三甲基乙酸)酯等。 Examples of polar oils such as ester oils include neopentyl alcohol tetraethyl hexanoate, ethyl cetyl ethyl hexanoate, jojoba oil, and lauric acid glutamic acid bis (phytosterol/octyldodecyl) ester. , triisosostearin, glyceryl diisostearate, triethylhexanoin, dimer linoleic acid (phytosterol / hawthorn) ester, dimerization Linoleic acid (phytosterol / isostear / cetyl / hard fat / hawthorn) ester, isopropyl palmitate, phytosteryl macadamiate, neopentyl alcohol four (mountain) Capric acid/benzoic acid/ethylhexanoate), ethylhexyl palmitate, myristyl myristate, tripropylene glycol bis(trimethylacetate), and the like.
液體油脂可列舉亞麻仁油、日本山茶(Camellia japonica)油、夏威夷豆油、玉米油、貂(mink)油、橄欖油、酪梨油、山茶花(sasanqua)油、蓖麻油、紅花油、葵花油、杏仁油、菜籽油、芝麻油、大豆油、花生油、三甘油、三辛酸甘油酯、三異軟脂酸甘油酯等。 Examples of the liquid fats include linseed oil, Camellia japonica oil, Hawaiian soybean oil, corn oil, mink oil, olive oil, avocado oil, sasanqua oil, castor oil, safflower oil, sunflower oil, Almond oil, rapeseed oil, sesame oil, soybean oil, peanut oil, triglycerin, tricaprylin, glyceryl triisostearate, and the like.
油分亦可將1種或2種以上併用後使用。 One or two or more kinds of oils may be used in combination.
本發明中,油分的調配量並無特別限定,通常係O/W乳化組成物總量中之0.1至20質量%、較佳為0.2至15質量%。 In the present invention, the amount of the oil component is not particularly limited, and is usually 0.1 to 20% by mass, preferably 0.2 to 15% by mass based on the total amount of the O/W emulsified composition.
本發明中,(C)成分之陰離子性界面活性劑係與上述(A)成分之高級脂肪族醇於水中形成α膠的成分。 In the present invention, the anionic surfactant of the component (C) and the component of the higher aliphatic alcohol of the component (A) form a component of α gel in water.
本發明所使用之陰離子性界面活性劑可列舉一般使用於化妝品、醫藥品、準藥品等外用組成物者。例如,脂肪酸皂(例如,月桂酸鈉、軟脂酸鈉等);高級烷基硫酸酯鹽(例如,月桂基硫酸鈉、月桂基硫酸鉀等);烷基醚硫酸酯鹽(例如,POE-月桂基硫酸三乙醇胺、POE-月桂基硫酸鈉等);N-醯基肌胺酸(例如,月桂醯基肌胺酸鈉(sodium lauroyl sarcosinate)等);高級脂肪酸醯胺磺酸鹽(例如,N-肉豆蔻醯基-N-甲基牛磺酸鈉、椰子油脂肪酸甲基牛磺酸鈉、月桂基甲基牛磺酸鈉等);磷酸酯鹽(POE-油基醚磷酸鈉、POE-硬脂醚磷酸等);磺基琥珀酸鹽(例如,二-2-乙基己基磺基琥珀酸鈉、單月桂醯基單乙醇醯胺聚氧伸乙基磺基琥珀酸鈉、月桂基聚丙二醇磺基琥珀酸鈉等);烷基苯磺酸鹽(例如,線性十二基苯磺酸鈉、線性十二基苯磺酸三乙醇胺、線性十二基苯磺酸等);高級脂肪酸酯硫酸酯鹽(例如,硬化椰子油脂肪酸甘油酯硫酸鈉等);N-醯基麩胺酸鹽(例如,N-月桂基醯基麩胺酸單鈉、N-硬脂醯基麩胺酸二鈉、N-肉豆蔻醯基-L-麩胺酸單鈉等);POE-烷基醚羧酸;POE-烷基烯丙基醚羧酸鹽;α-烯烴磺酸鹽;高級脂肪酸酯磺酸鹽;二級醇硫酸酯鹽;高級脂肪酸烷醇醯胺硫酸酯鹽;月桂醯基單乙醇醯胺琥珀酸鈉;N-軟脂醯基天冬胺酸二(三乙醇胺);酪蛋白鈉等。 The anionic surfactant used in the present invention is generally used for external compositions such as cosmetics, pharmaceuticals, and quasi-drugs. For example, fatty acid soaps (eg, sodium laurate, sodium palmitate, etc.); higher alkyl sulfate salts (eg, sodium lauryl sulfate, potassium lauryl sulfate, etc.); alkyl ether sulfates (eg, POE- Triethanolamine lauryl sulfate, POE-sodium lauryl sulfate, etc.; N-mercaptocreatine (for example, sodium lauroyl sarcosinate, etc.); higher fatty acid decyl sulfonate (for example, N-myristyl-N-methyl taurine, coconut oil fatty acid methyl taurate, sodium lauryl methyl taurate, etc.; phosphate ester (POE-oleyl ether sodium phosphate, POE - stearyl ether phosphate, etc.; sulfosuccinate (for example, sodium di-2-ethylhexylsulfosuccinate, monolaurinyl monoethanol decylamine polyoxyethyl sulfosuccinate, lauryl Polypropylene glycol sulfosuccinate, etc.; alkylbenzene sulfonate (for example, sodium linear dodecylbenzenesulfonate, linear dodecylbenzenesulfonic acid triethanolamine, linear dodecylbenzenesulfonic acid, etc.); Acid ester sulfate (for example, hardened coconut oil fatty acid glyceride sodium sulfate, etc.); N-mercapto glutamate (for example, N-lauryl thiol glutamic acid single , N-stearyl glutamic acid disodium, N-myristyl-L-glutamic acid monosodium, etc.; POE-alkyl ether carboxylic acid; POE-alkyl allyl ether carboxylate; --olefin sulfonate; higher fatty acid ester sulfonate; secondary alcohol sulfate; higher fatty acid alkanolamine sulfate; lauryl monoethanol amide sodium succinate; N-lipid base Aspartic acid bis(triethanolamine); casein sodium and the like.
較佳之陰離子性界面活性劑之一例,可列舉下述通式(I)所表示之長鏈醯基磺酸鹽型陰離子性界面活性劑。 An example of a preferred anionic surfactant is a long-chain mercaptosulfonate-type anionic surfactant represented by the following formula (I).
R1CO-a-(CH2)nSO3M1 (I) R 1 CO-a-(CH 2 ) n SO 3 M 1 (I)
通式(I)中,R1CO-係表示碳原子數10至22之飽和或不飽和脂肪族醯基。R1CO可例示如C11H23CO、C12H25CO、C13H27CO、C14H29CO、C15H31CO、C16H33CO、C17H35CO、椰子脂肪酸(coconut fatty acid)殘基、油椰子(oil palm)脂肪酸殘基等(脂肪酸殘基係指從脂肪酸之羧基除去OH基後而得之基)。又,從安全性等之觀點來看,R1CO係以碳原子數12至22者為更佳。 In the formula (I), R 1 CO- represents a saturated or unsaturated aliphatic fluorenyl group having 10 to 22 carbon atoms. R 1 CO can be exemplified by C 11 H 23 CO, C 12 H 25 CO, C 13 H 27 CO, C 14 H 29 CO, C 15 H 31 CO, C 16 H 33 CO, C 17 H 35 CO, coconut fatty acid. (coconut fatty acid) residue, oil palm fatty acid residue, etc. (a fatty acid residue refers to a group obtained by removing an OH group from a carboxyl group of a fatty acid). Further, from the viewpoint of safety and the like, it is more preferable that R 1 CO is 12 to 22 carbon atoms.
a為-O-或-NR-(惟,R表示氫原子、或碳原子數1至3之烷基)。該等為電子供應性基。a係以-O-、-NH-、-N(CH3)-為較佳。 a is -O- or -NR- (except that R represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms). These are electronic supply bases. a is preferably -O-, -NH- or -N(CH 3 )-.
M1係表示鹼金屬類、鹼土金屬類、銨或有機胺類。M1可例示例如鋰、鉀、鈉、鈣、鎂、銨、單乙醇胺、二乙醇胺、三乙醇胺、牛磺酸鈉、N-甲基牛磺酸鈉等。 M 1 represents an alkali metal, an alkaline earth metal, an ammonium or an organic amine. M 1 can be exemplified by, for example, lithium, potassium, sodium, calcium, magnesium, ammonium, monoethanolamine, diethanolamine, triethanolamine, sodium taurate, sodium N-methyltaurate or the like.
n係表示1至3之整數。 The n system represents an integer of 1 to 3.
上述通式(I)中,關於a表示-O-之化合物,亦即,長鏈醯基2-羥乙磺酸鹽型陰離子性界面活性劑,係可例示椰油醯基2-羥乙磺酸鹽、硬脂醯基2-羥乙磺酸鹽、月桂2-羥乙磺酸鹽、肉豆蔻醯基2-羥乙磺酸鹽等。 In the above formula (I), a compound in which a represents -O-, that is, a long-chain mercapto 2-hydroxyethanesulfonate-type anionic surfactant, is exemplified by cocoyl 2-hydroxyethanesulfonate. An acid salt, a stearyl 2-hydroxyethanesulfonate, a lauryl 2-hydroxyethanesulfonate, a myristyl 2-hydroxyethanesulfonate or the like.
上述通式(I)中,關於a表示-NH-之化合物,亦即,長鏈醯基牛磺酸鹽型陰離子性界面活性劑,係可例示N-月桂醯基牛磺酸鹽、N-椰油醯基-N-乙醇牛磺酸鹽、N-肉豆蔻醯基牛磺酸鹽、N-硬脂醯基牛磺酸鹽等。 In the above formula (I), a compound in which a represents -NH-, that is, a long-chain mercapto taurate-type anionic surfactant, may be exemplified as N-lauroyl taurate, N- Cocoyl-N-ethanol taurate, N-myristyl taurate, N-stearyl sulfonate taurate, and the like.
上述通式(I)中,關於a表示-N(CH3)-之化合物,亦即,長鏈醯基甲基牛磺酸鹽型陰離子性界面活性劑,係可例示N-月桂醯基-N-甲基牛磺酸鹽、N-軟脂醯基-N-甲基牛磺酸鹽、N-硬脂醯基-N-甲 基牛磺酸鹽、N-椰油醯基-N-甲基牛磺酸鹽等。 In the above formula (I), a compound in which a represents -N(CH 3 )-, that is, a long-chain mercaptomethyltaurate-type anionic surfactant, can be exemplified as N-lauric acid- N-methyltaurate, N-lipidinyl-N-methyltaurate, N-stearyl-N-methyltaurate, N-cocoyl-N- Methyl taurates and the like.
該等之中,較佳為長鏈醯基甲基牛磺酸鹽型陰離子性界面活性劑,特佳者為N-硬脂醯基-N-甲基牛磺酸鈉等N-硬脂醯基-N-甲基牛磺酸鹽。 Among these, a long-chain mercaptomethyltaurate-type anionic surfactant is preferred, and N-stearin such as N-stearyl-N-methyltaurate is preferred. Base-N-methyltaurate.
此外,其他之較佳陰離子性界面活性劑之例,亦可列舉下述通式(II)所示之長鏈醯基麩胺酸鹽型陰離子性界面活性劑。 Further, examples of other preferable anionic surfactants include long-chain mercapto glutamate type anionic surfactants represented by the following formula (II).
R2CO-NH-CH(COOM2)-CH2CH2-COOM2 (II) R 2 CO-NH-CH(COOM 2 )-CH 2 CH 2 -COOM 2 (II)
R2CO-係表示碳原子數16至22之飽和或不飽和脂肪族醯基。M2係表示鹼金屬類、鹼土金屬類、銨或有機胺類。M1可列舉例如鋰、鉀、鈉、鈣、鎂、銨、單乙醇胺、二乙醇胺、三乙醇胺、牛磺酸鈉、N-甲基牛磺酸鈉等。 The R 2 CO- is a saturated or unsaturated aliphatic fluorenyl group having 16 to 22 carbon atoms. The M 2 system represents an alkali metal, an alkaline earth metal, an ammonium or an organic amine. M 1 may, for example, be lithium, potassium, sodium, calcium, magnesium, ammonium, monoethanolamine, diethanolamine, triethanolamine, sodium taurate or sodium N-methyltaurate.
代表例係可列舉例如N-硬脂醯基-L-麩胺酸鈉、N-軟脂醯基-L-麩胺酸鈉、N-硬脂醯基麩胺酸-L-三乙醇胺等。 Representative examples include, for example, N-stearyl sulfonyl-L-glutamate, N-lipidinyl-L-glutamate, N-stearyl glutamic acid-L-triethanolamine, and the like.
本發明中,陰離子性界面活性劑係在O/W乳化組成物總量中為0.01至5質量%、較佳為0.02至3質量%。陰離子性界面活性劑亦可併用1種或2種以上而使用。 In the present invention, the anionic surfactant is 0.01 to 5% by mass, preferably 0.02 to 3% by mass based on the total amount of the O/W emulsified composition. The anionic surfactant may be used alone or in combination of two or more.
在本發明所得之O/W乳化組成物之乳化粒子界面,(A)高級脂肪族醇與(C)陰離子性界面活性劑係形成包含片狀2分子膜的凝集體,而成為所謂α膠之狀態。 In the emulsified particle interface of the O/W emulsified composition obtained by the present invention, (A) the higher aliphatic alcohol and the (C) anionic surfactant form an aggregate comprising a flaky 2-molecular film, and become a so-called alpha gel. status.
因為α膠係有助於使O/W乳化組成物安定化,故在O/W乳化組成物中,相對於(B)油分10質量份,(A)高級脂肪族醇與(C)陰離子性界面活性劑之合計量較佳為0.5至10質量份。未達0.5質量份時,α膠量少,故會有使所得O/W乳化組成物之安定性不充分之情形。此外,當超過10質量份時,由於α膠過多,而會有就使 用感之觀點而言為不佳之傾向。 Since the α-gel system contributes to the stabilization of the O/W emulsified composition, (A) higher aliphatic alcohol and (C) anionic property in the O/W emulsified composition relative to (B) oil component 10 parts by mass. The total amount of the surfactant is preferably from 0.5 to 10 parts by mass. When the amount is less than 0.5 part by mass, the amount of the α-gel is small, so that the stability of the obtained O/W emulsified composition may be insufficient. In addition, when it exceeds 10 parts by mass, since there are too many α gels, there will be It is a tendency to be unsatisfactory from the point of view of feeling.
此外,如前述,α膠係於DSC測定時表現吸熱峰,吸熱峰溫度可被視為α膠的熔點。由於α膠在熔點以上之溫度會發生低黏度化,故有對O/W乳化組成物之高溫安定性造成影響之可能性。 Further, as described above, the α gum is an endothermic peak when measured by DSC, and the endothermic peak temperature can be regarded as the melting point of the α gel. Since the α-gel has a low viscosity at a temperature above the melting point, there is a possibility that the high-temperature stability of the O/W emulsified composition is affected.
因此,就O/W乳化組成物之高溫安定性之觀點來看,α膠的熔點係以高者為佳,較佳為60℃以上,更佳為65℃以上。 Therefore, from the viewpoint of high-temperature stability of the O/W emulsified composition, the melting point of the α-gel is preferably higher, preferably 60 ° C or higher, more preferably 65 ° C or higher.
(D)成分之伸烷基氧化物衍生物,可列舉例如下述通式(1)所示者。 The alkylene oxide derivative of the component (D) may, for example, be represented by the following formula (1).
R1O-[(AO)m(EO)n]-R2 (1) R 1 O-[(AO) m (EO) n ]-R 2 (1)
通式(1)中,AO為碳數3至4之氧伸烷基,具體而言,可列舉氧伸丙基、氧伸丁基、氧伸異丁基、氧三亞甲基(oxytrimethylene)、氧四亞甲基等。較佳為氧伸丙基、氧伸丁基。 In the formula (1), AO is an oxygen-extended alkyl group having 3 to 4 carbon atoms, and specific examples thereof include an oxygen-extension propyl group, an oxygen-extension butyl group, an oxygen-isobutyl group, and an oxytrimethylene group. Oxytetramethylene and the like. Preferred are oxygen-extended propyl groups and oxygen-extended butyl groups.
就本發明而言,在碳數3至4之氧伸烷基與氧伸乙基之合計中,該氧伸烷基之比率較佳係20至80質量%,更佳係30至70質量%。氧伸烷基之比率若過小,則微細化效果降低;若過大,則不溶於水而難以使用。 In the present invention, in the total of the oxygen alkyl group having 3 to 4 carbon atoms and the oxygen stretching alkyl group, the ratio of the oxygen alkyl group is preferably 20 to 80% by mass, more preferably 30 to 70% by mass. . If the ratio of the oxygen alkyl group is too small, the effect of miniaturization is lowered; if it is too large, it is insoluble in water and difficult to use.
m為碳數3至4之氧伸烷基之平均加成莫耳數,n為氧伸乙基之平均加成莫耳數,分別可為1至70之範圍,較佳為2至60。又,m與n之合計若過大則會發黏,故(m+n)較佳為100以下。 m is the average addition mole number of the oxygen alkyl group having 3 to 4 carbon atoms, and n is the average addition mole number of the oxygen extension ethyl group, and may be in the range of 1 to 70, preferably 2 to 60, respectively. Further, if the total of m and n is too large, it is sticky, so (m + n) is preferably 100 or less.
伸乙基氧化物及碳數3至4之伸烷基氧化物的加成順序係無特別指定。而且,氧伸乙基與碳數3至4之氧伸烷基可為嵌段狀加成,亦可為無規狀加成。就嵌段狀而言,不只包含2段嵌段,亦包含3段以上之嵌段。較佳可列舉無規狀加成者。 The order of addition of the ethylene oxide and the alkylene oxide having a carbon number of 3 to 4 is not specifically specified. Further, the oxygen-extended ethyl group and the oxygen-and-alkyl group having a carbon number of 3 to 4 may be a block-like addition or a random addition. In the case of the block form, it includes not only the two-stage block but also the block of three or more stages. Preferably, a random addition is exemplified.
R1及R2為碳數1至4之烷基,可列舉甲基、乙基、正丙基、異丙基、正丁基、第二丁基、第三丁基等。較佳為甲基、乙基。若為5以上之烴基則親水性會降低,變得不易溶於水。R1、R2可為相同或相異。 R 1 and R 2 are an alkyl group having 1 to 4 carbon atoms, and examples thereof include a methyl group, an ethyl group, a n-propyl group, an isopropyl group, a n-butyl group, a second butyl group, and a third butyl group. It is preferably a methyl group or an ethyl group. When it is a hydrocarbon group of 5 or more, hydrophilicity will fall and it becomes hard to melt|dissolve in water. R 1 and R 2 may be the same or different.
本發明之伸烷基氧化物衍生物係可以公知的方法製造。例如,可藉由對於具有羥基之化合物加成聚合伸乙基氧化物及碳數3至4之伸烷基氧化物後,在鹼觸媒之存在下使鹵化烷基進行醚反應而得到。 The alkylene oxide derivative of the present invention can be produced by a known method. For example, it can be obtained by subjecting a halogenated alkyl group to an ether reaction in the presence of a base catalyst by addition polymerization of a compound having a hydroxyl group and an alkylene oxide having a carbon number of 3 to 4.
通式(1)之伸烷基氧化物衍生物之較佳例係可列舉例如:POE(14)POP(7)二甲基醚、POE(36)POP(41)二甲基醚、POE(55)POP(28)二甲基醚、POE(22)POP(40)二甲基醚、POE(35)POP(40)二甲基醚、POE(50)POP(40)二甲基醚、POE(11)POP(9)二甲基醚等,惟並不限定於該等。 Preferred examples of the alkylene oxide derivative of the formula (1) include, for example, POE (14) POP (7) dimethyl ether, POE (36) POP (41) dimethyl ether, and POE ( 55) POP (28) dimethyl ether, POE (22) POP (40) dimethyl ether, POE (35) POP (40) dimethyl ether, POE (50) POP (40) dimethyl ether, POE (11) POP (9) dimethyl ether or the like, but is not limited thereto.
於本發明中,乳化部分中係調配(D)伸烷基氧化物衍生物1至30質量%,較佳為3至25質量%。 In the present invention, the emulsified portion is formulated with (D) an alkylene oxide derivative in an amount of from 1 to 30% by mass, preferably from 3 to 25% by mass.
只要(D)伸烷基氧化物衍生物在乳化部分中為1至30質量%,即亦可調配於第2水相中。因此,本發明所得之O/W乳化組成物中之伸烷基氧化物衍生物量幾乎不受限制。 As long as the (D) alkylene oxide derivative is from 1 to 30% by mass in the emulsified portion, it can be formulated in the second aqueous phase. Therefore, the amount of the alkylene oxide derivative in the O/W emulsified composition obtained by the present invention is hardly limited.
本發明中,水係至少包含在用以調製乳化部分之第1水相中。第1水相中所包含之水,只要使用可調整乳化部分的量即可,通常係在乳化部分中為55至90質量%,較佳為60至85質量%。 In the present invention, the water system is contained at least in the first aqueous phase for modulating the emulsified portion. The water contained in the first aqueous phase may be an amount of the emulsifiable portion, and is usually 55 to 90% by mass, preferably 60 to 85% by mass in the emulsified portion.
此外,較佳為亦包含在用以冷卻乳化部分之第2水相中。 Further, it is preferably included in the second aqueous phase for cooling the emulsified portion.
本發明所得之O/W乳化組成物之水的總調配量雖無特別限 定,但通常是O/W乳化組成物總量中的40至95質量%。 The total amount of water of the O/W emulsified composition obtained by the present invention is not particularly limited. It is usually 40 to 95% by mass in the total amount of the O/W emulsified composition.
第1水相係以O/W乳化組成物總量中的25至50質量%為較佳,30至45質量%為更佳。第1水相若過少則會有無法得到安定之O/W乳化組成物之情形,第1水相若過多則冷卻乳化部分之第2水相會變少,故經濟性差。 The first aqueous phase is preferably 25 to 50% by mass in the total amount of the O/W emulsified composition, more preferably 30 to 45% by mass. If the first aqueous phase is too small, the stabilized O/W emulsified composition may not be obtained. If the first aqueous phase is too large, the second aqueous phase of the cooled emulsified portion will be small, so that the economy is poor.
此外,第2水相係以O/W乳化組成物總量中之40至75質量%為較佳,45至70質量%為更佳。第2水相若未達40質量%,則無法得到充分的冷卻效果,相對地則需要更多的冷卻能量,故經濟性差。此外,若超過75質量%,則調製O/W乳化部分之第1水相會變少,故會有變得難以調製安定的O/W乳化組成物之傾向。 Further, the second aqueous phase is preferably 40 to 75 mass% of the total amount of the O/W emulsified composition, more preferably 45 to 70 mass%. If the second aqueous phase is less than 40% by mass, a sufficient cooling effect cannot be obtained, and relatively more cooling energy is required, so that the economy is poor. In addition, when it exceeds 75% by mass, the first aqueous phase in which the O/W emulsified portion is prepared is reduced, so that it tends to be difficult to prepare a stable O/W emulsified composition.
此外,添加至O/W乳化部分中之第2水相(剩餘部分的水相)的溫度係以10至35℃為較佳,以15至30℃為特佳。若未達10℃,則會變得需要過多使第2水相變冷之能量,而有經濟性差之傾向。此外,若超過35℃,則無法得到充分的冷卻效果,相對地則需要更多的冷卻能量,故經濟性差。 Further, the temperature of the second aqueous phase (the remaining aqueous phase) added to the O/W emulsified portion is preferably from 10 to 35 ° C, particularly preferably from 15 to 30 ° C. If it is less than 10 ° C, it will become too much energy to cool the second aqueous phase, and there is a tendency to be economically poor. Further, when it exceeds 35 ° C, a sufficient cooling effect cannot be obtained, and relatively more cooling energy is required, which is inferior in economy.
本發明之O/W乳化組成物中,亦可在不損及本發明效果之範圍,而在上述必須成分之外調配一般使用於化妝品、醫藥品等之成分。該成分係可列舉例如後述者,惟不限於該等:1,3-丁二醇、二丙二醇、異戊二醇、1,2-戊二醇、1,2-己二醇、2-甲基-1,3-丙醇、乙基卡必醇、1,2-丁二醇、甘油等水性溶媒;聚乙二醇及其單-或二-烷基醚、聚乙二醇-聚丙二醇共聚合物及其單-或二-烷基醚、山梨醇、木糖醇、麥芽糖醇、黏多醣、玻尿酸、硫酸軟骨素(chondroitin salfate)、幾丁聚糖(chitosan)等保濕 劑;甲基纖維素、乙基纖維素、阿拉伯膠、聚乙烯醇等增黏劑;乙醇等有機溶劑;丁基羥基甲苯、生育酚、植酸(phytic acid)等抗氧化劑;安息香酸、水楊酸、山梨酸、對羥基安息香酸酯(對羥基安息香酸乙酯、對羥基安息香酸丁酯等)、六氯芬(hexachlorophene)等抗菌防腐劑;甘胺酸、丙胺酸、纈胺酸、白胺酸、絲胺酸、蘇胺酸、苯基丙胺酸、酪胺酸、天冬胺酸、天冬醯胺、麩胺酸、牛磺酸、精胺酸、組胺酸等胺基酸與其鹽;醯基肌胺酸(例如月桂醯基肌胺酸鈉)、麩胱甘肽(glutathione)、檸檬酸、蘋果酸、酒石酸、乳酸等有機酸及其鹽;維生素A及其衍生物;維生素B6鹽酸鹽、維生素B6三軟脂酸酯、維生素B6二辛酸酯、維生素B2及其衍生物、維生素B12、維生素B15及其衍生物等維生素B類;抗壞血酸、抗壞血酸磷酸酯(鹽)、抗壞血酸二軟脂酸酯等維生素C類;α-生育酚、β-生育酚、γ-生育酚、維生素E乙酸酯、維生素E菸鹼酸酯等維生素E類;維生素D類、維生素H、泛酸(pantothenic acid)、泛雙硫醇(pantethine)等維生素類;菸鹼酸醯胺、菸鹼酸苄酯、γ-穀維素、尿囊素、甘草酸(glycyrrhizinic acid)(鹽)、甘草次酸(glycyrrhetinic acid)及其衍生物、日本扁柏酚(hinokitiol)、酸模素(musizin)、甜沒藥醇(bisabolol)、桉油醇(eucalyptol)、瑞香草酚(thymol)、肌醇(inositol)、皂苷(saponin)類(柴胡皂甘(saikosaponin)、人蔘皂苷、絲瓜皂苷、無患子皂苷等)、 泛醯基乙基醚、乙炔基雌二醇、傳明酸、頭花千金藤素(cepharanthine)、胎盤萃取物(placenta extract)等各種藥劑;羊蹄(Rumex japonicus)、苦參、萍蓬草(Nuphar japonicum)、柑橘、鼠尾草(sage)、瑞香草(thyme)、高山蓍草(Achillea alpina)、錦葵(mallow)、川芎、當藥(Swertia japonica)、當歸、唐檜、樺木(birch)、問荊(Equisetum arvense)、絲瓜、馬栗(marronnier)、虎耳草、山金車(arnica)、百合、蓬草(Japanese mugwort)、芍藥、蘆薈、梔子、日本花柏(sawara)等之以有機溶劑、醇、多元醇、水、水性醇等所萃取之天然萃取物;氯化硬脂基三甲基銨、氯化苄烷銨(benzalkonium chloride)、氧化月桂基胺等陽離子界面活性劑;聚氧伸乙基脂肪酸甘油酯、聚氧伸乙基-甲基聚矽氧烷共聚物、脂肪酸聚氧伸乙基山梨醇酐、聚氧伸乙基烷基醚、麥芽糖醇羥基脂肪族烷基醚、烷基化多糖、烷基葡糖苷、蔗糖脂肪酸酯、聚氧伸乙基硬化蓖麻油甘油等非離子性界面活性劑;乙二胺四乙酸二鈉、乙二胺四乙酸三鈉、檸檬酸鈉、聚磷酸鈉、間磷酸鈉、葡萄糖酸等螯合劑(sequestrant);氫氧化鉀、氫氧化鈉、三乙醇胺等中和劑。 In the O/W emulsified composition of the present invention, components generally used in cosmetics, pharmaceuticals, and the like may be blended in addition to the above-mentioned essential components, without impairing the effects of the present invention. The component may, for example, be described later, but is not limited thereto: 1,3-butanediol, dipropylene glycol, isoprene glycol, 1,2-pentanediol, 1,2-hexanediol, 2-methyl Aqueous solvent such as 1,3-propanol, ethyl carbitol, 1,2-butanediol, glycerin; polyethylene glycol and its mono- or di-alkyl ether, polyethylene glycol-polypropylene glycol Co-polymer and its mono- or di-alkyl ether, sorbitol, xylitol, maltitol, mucopolysaccharide, hyaluronic acid, chondroitin salfate, chitosan and other moisturizers Agent; methyl cellulose, ethyl cellulose, gum arabic, polyvinyl alcohol and other tackifiers; organic solvents such as ethanol; butyl hydroxy toluene, tocopherol, phytic acid and other antioxidants; benzoic acid, water Salicylic acid, sorbic acid, p-hydroxybenzoic acid ester (ethyl p-hydroxybenzoate, butyl p-hydroxybenzoate, etc.), antibacterial preservatives such as hexachlorophene; glycine, alanine, lysine, Amino acids such as leucine, serine, sulphate, phenylalanine, tyrosine, aspartic acid, aspartame, glutamic acid, taurine, arginine, histidine And its salts; thiol sarcosine (such as sodium lauryl sarcosinate), glutathione, citric acid, malic acid, tartaric acid, lactic acid and other organic acids and salts thereof; vitamin A and its derivatives; Vitamin B6 hydrochloride, vitamin B6 tri-palmitate, vitamin B6 dioctanoate, vitamin B2 and its derivatives, vitamin B12, vitamin B15 and its derivatives, vitamin B; ascorbic acid, ascorbyl phosphate (salt) , vitamin C such as ascorbyl di-palmitate; α-tocopherol, - vitamin E such as tocopherol, gamma-tocopherol, vitamin E acetate, vitamin E nicotinic acid ester; vitamins such as vitamin D, vitamin H, pantothenic acid, pantethine; Nicotinic acid amide, benzyl nicotinic acid, γ-oryzanol, allantoin, glycyrrhizinic acid (salt), glycyrrhetinic acid and its derivatives, hinokitiol , musizin, bisabolol, eucalyptol, thymol, inositol, saponin (saikosaponin), human Saponins, loofah saponins, sapindus saponins, etc.) Various agents such as ubiquinone ethyl ether, ethinyl estradiol, tranexamic acid, cepharanthine, placenta extract, etc.; Rumex japonicus, Sophora flavescens, Pleurotus ostreatus (Rumex japonicus) Nuphar japonicum), citrus, sage, thyme, Achillea alpina, mallow, chuanxiong, Swertia japonica, angelica, tang, birch ), Equisetum arvense, loofah, horse chestnut (marronnier), saxifrage, arnica, lily, Japanese mugwort, peony, aloe, medlar, sawara Such as natural extracts extracted with organic solvents, alcohols, polyols, water, aqueous alcohols, etc.; cation interfaces such as stearyltrimethylammonium chloride, benzalkonium chloride, and laurylamine oxide Active agent; polyoxyethylene ethyl glyceride, polyoxyethylene ethyl methacrylate copolymer, fatty acid polyoxyethylene ethyl sorbitol, polyoxyethylene ethyl ether, maltitol hydroxy fat Alkyl ethers, alkylated polysaccharides, alkyl glucosides, sucrose fatty acid esters, poly Oxygen-extended ethyl hardened castor oil glycerin and other nonionic surfactant; ethylenediaminetetraacetic acid disodium, ethylenediaminetetraacetic acid trisodium, sodium citrate, sodium polyphosphate, sodium metaphosphate, gluconic acid and other chelating agents ( Sequestrant); neutralizer such as potassium hydroxide, sodium hydroxide or triethanolamine.
此外,亦可在不損及安定性等之範圍,適宜調配其他例如香料、去角質劑、粉末、色材、美白劑、紫外線吸收劑和紫外線散射劑等抗紫外線劑等。 Further, other anti-UV agents such as a fragrance, an exfoliating agent, a powder, a coloring material, a whitening agent, an ultraviolet absorber, and an ultraviolet ray scattering agent may be suitably blended in such a range as not to impair the stability and the like.
就各成分而言,通常,親油性成分係調配於油相,親水性成分係調配於第1水相及/或第2水相。 In the case of each component, usually, the lipophilic component is blended in the oil phase, and the hydrophilic component is blended in the first aqueous phase and/or the second aqueous phase.
本發明之O/W乳化組成物係可適合用於作為例如化妝料、醫 藥、準藥品中可適用於皮膚、頭髪等之身體的外用組成物等。例如可用於:乳液、乳霜、按摩乳霜、潔膚乳霜、精華液、身體用乳霜等護膚化妝料;護髮乳霜(haircream)、護髮劑(conditioner)、潤髮劑等護髮化妝料;防曬劑等防曬化妝料;潔膚劑(cleansing)、卸妝劑等洗淨料;粉底(foundation)等彩妝化妝料等;整髪料等毛髪化妝料等。 The O/W emulsified composition of the present invention can be suitably used as, for example, a cosmetic, a medical Among the drugs and quasi-drugs, it can be applied to external compositions of the skin such as skin and hair. For example, it can be used for: lotion, cream, massage cream, cleansing cream, essence, body cream, etc.; hair cream, conditioner, conditioner, etc. Hair cosmetics; sunscreen lotion and other sunscreen cosmetics; cleansing (cleansing), makeup remover and other cleansing materials; foundation (foundation) and other make-up cosmetics;
以下列舉具體例以更詳細地說明本發明,惟本發明並不限定於此。又,若無特別限定,則調配量係皆以質量%表示。 The present invention will be described in more detail below by way of specific examples, but the invention is not limited thereto. Further, unless otherwise specified, the blending amounts are expressed in mass%.
首先,說明本發明所採用之試驗法。 First, the test method employed in the present invention will be described.
以電子顯微鏡觀察剛調製後之O/W乳化組成物之乳化粒徑,並藉由下述評估基準進行評估。 The emulsified particle diameter of the newly prepared O/W emulsified composition was observed with an electron microscope and evaluated by the following evaluation criteria.
○:沒有大於5μm之乳化粒子。 ○: No emulsified particles larger than 5 μm.
△:沒有大於10μm之乳化粒子。 △: No emulsified particles larger than 10 μm.
×:有大於10μm之乳化粒子。 ×: There are emulsified particles larger than 10 μm.
使用B型黏度計(轉子編號3號,轉子旋轉數12rpm)於30℃測定剛調製後之O/W乳化組成物的黏度。 The viscosity of the O/W emulsified composition immediately after the preparation was measured at 30 ° C using a B-type viscometer (rotor No. 3, rotor rotation number: 12 rpm).
使用在水中會形成α膠之高級脂肪族醇與陰離子性界面活性劑,依下述表1之組成調製O/W乳化組成物。製造方法係如後述。 The O/W emulsified composition was prepared according to the composition of Table 1 below using a higher aliphatic alcohol and an anionic surfactant which formed α-gel in water. The manufacturing method will be described later.
(1)將第1水相(成分1至6)加熱混合,並於80至85℃使其溶解。 (1) The first aqueous phase (components 1 to 6) is heated and mixed, and dissolved at 80 to 85 °C.
(2)將油相(成分7至11)加熱混合,並於80至85℃使其溶解。 (2) The oil phase (ingredients 7 to 11) was heated and mixed, and dissolved at 80 to 85 °C.
(3)將第1水相及油相以均質機攪拌混合,調製乳化部分。 (3) The first aqueous phase and the oil phase are stirred and mixed by a homogenizer to prepare an emulsified portion.
(4)一邊以均質機攪拌乳化部分,一邊將室溫(約20℃)之第2水相(成分12至13)混合至乳化部分中,得到O/W乳化組成物。 (4) While stirring the emulsified portion with a homogenizer, the second aqueous phase (components 12 to 13) at room temperature (about 20 ° C) was mixed into the emulsified portion to obtain an O/W emulsified composition.
(1)將水相(成分1至6及成分12至13)加熱混合,並於80至85℃使其溶解。 (1) The aqueous phase (components 1 to 6 and components 12 to 13) was heated and mixed, and dissolved at 80 to 85 °C.
(2)將油相(成分7至11)加熱混合,並於80至85℃使其溶解。 (2) The oil phase (ingredients 7 to 11) was heated and mixed, and dissolved at 80 to 85 °C.
(3)以均質機將水相及油相攪拌混合並進行乳化,以Onlator冷卻至40℃為止,得到O/W乳化組成物。 (3) The aqueous phase and the oil phase were stirred and mixed by a homogenizer, emulsified, and cooled to 40 ° C by Onlator to obtain an O/W emulsified composition.
試料1-1之組成係可藉由使用Onlator之以往之方法(製法b)而得到乳化粒徑微細的O/W乳化組成物之組成。 The composition of the sample 1-1 can be obtained by using the conventional method of Onlator (Process b) to obtain a composition of an O/W emulsified composition having a fine emulsified particle diameter.
試料1-2及試料1-3皆係使用以第2水相將乳化部分進行冷卻之方法(製法a)而調製與試料1-1相同組成之O/W乳化組成物之情形。 In the case of the sample 1-2 and the sample 1-3, the O/W emulsified composition having the same composition as that of the sample 1-1 was prepared by a method of cooling the emulsified portion in the second aqueous phase (Production Method a).
當如試料1-2般於乳化部分中不存在(D)伸烷基氧化物衍生物時,即使例如在冷卻用之第2水相中存在(D)伸烷基氧化物衍生物,仍無法得到乳化粒徑微細的O/W乳化組成物。 When the (D) alkylene oxide derivative is not present in the emulsified portion as in the case of the sample 1-2, even if the (D) alkylene oxide derivative is present in the second aqueous phase for cooling, for example, An O/W emulsified composition having a fine emulsified particle size was obtained.
相對於此,當如試料1-3般於乳化部分中存在(D)伸烷基氧化物衍生物時,則可與試料1-1同樣地得到乳化粒徑微細的O/W乳化組成物。此外,就黏度而言,亦可得到與試料1-1相同程度之O/W乳化組成物。 On the other hand, when the (D) alkylene oxide derivative is present in the emulsified portion as in the case of the sample 1-3, an O/W emulsified composition having a fine emulsified particle diameter can be obtained in the same manner as in the sample 1-1. Further, in terms of viscosity, an O/W emulsified composition similar to the sample 1-1 was obtained.
此外,即使是當如試料1-4般形成α膠之陰離子性界面活性劑為不同時,若在乳化部分中存在(D)伸烷基氧化物衍生物,則可與試料1-3同樣地得到乳化粒徑微細的O/W乳化組成物。 In addition, even when the (A) alkylene oxide derivative is present in the emulsified portion, the anionic surfactant which forms the α-gel as in the case of the sample 1-4 is different, similarly to the sample 1-3. An O/W emulsified composition having a fine emulsified particle size was obtained.
在表1之試料1-3中,改變乳化部分中之(D)伸烷基氧化物衍生物濃度並進行檢討。O/W乳化組成物之製造係依照製法a進行。 In the sample 1-3 of Table 1, the concentration of the (D) alkylene oxide derivative in the emulsified portion was changed and reviewed. The production of the O/W emulsified composition is carried out in accordance with Process a.
如表2所示,乳化部分中之(D)伸烷基氧化物衍生物之濃度無論是過少或過多,乳化粒徑皆會有粗大化之傾向。此外,相較於 使用Onlator等之藉由以往方法所調製之相同組成的O/W乳化組成物,其黏度係降低。 As shown in Table 2, the concentration of the (D) alkylene oxide derivative in the emulsified portion was too small or too large, and the emulsified particle size tends to coarsen. In addition, compared to The viscosity of the O/W emulsified composition of the same composition prepared by the conventional method, such as Onlator, is lowered.
因此,可認為乳化部分中之(D)伸烷基氧化物衍生物的濃度係以1至30質量%為佳,更進一步係以3至25質量%為宜。 Therefore, it is considered that the concentration of the (D) alkylene oxide derivative in the emulsified portion is preferably from 1 to 30% by mass, more preferably from 3 to 25% by mass.
依下述表3之組成並依照製法a調製O/W乳化組成物。 The O/W emulsified composition was prepared according to the composition of Table 3 below in accordance with Process A.
由試料3-1至3-3可知,乳化部分中,即使使用其他水性溶媒和醇類取代(D)伸烷基氧化物衍生物,也無法得到乳化粒徑微細的O/W乳化組成物。 From the samples 3-1 to 3-3, it was found that even in the emulsified portion, the O/W emulsified composition having a fine emulsified particle diameter could not be obtained even if another aqueous solvent and an alcohol were used instead of the (D) alkylene oxide derivative.
此外,試料3-4及試料3-5雖為在使用於水中形成α膠的陰離子性界面活性劑與高級脂肪族醇的O/W乳化組成物中,於乳化部 分中調配已知具有黏度安定化效果之鹽類和陽離子性界面活性劑之情形,但是即使使用該等成分,仍無法使乳化粒徑微細化。 Further, Sample 3-4 and Sample 3-5 are in an O/W emulsified composition of an anionic surfactant and a higher aliphatic alcohol which are used in the formation of α-gel in water, in the emulsification section. In the case where a salt having a viscosity stabilization effect and a cationic surfactant are known, the emulsified particle size cannot be made fine even if these components are used.
因此可理解到,在調製高濃度之乳化部分並於其中混合低溫的剩餘部分的水相之方法(製法a)中,O/W乳化組成物之乳化粒徑的微細化效果係對於(D)伸烷基氧化物衍生物有專一性。 Therefore, it can be understood that in the method of preparing a high-concentration emulsified portion and mixing the water phase of the remaining portion of the low temperature (Process a), the aging effect of the emulsified particle diameter of the O/W emulsified composition is (D) The alkylene oxide derivatives are specific.
另外,改變(D)伸烷基氧化物衍生物並進行檢討。O/W乳化組成物之製造係依照製法a進行。 Further, the (D) alkylene oxide derivative was changed and reviewed. The production of the O/W emulsified composition is carried out in accordance with Process a.
如表4所示,雖然只要是通式(1)所示之伸烷基氧化物衍生物即會得到微細化效果,惟在氧伸乙基與氧伸烷基之合計中,氧伸 烷基所佔之比率若變小,則微細化效果會有降低之傾向。此外,前述比率若變大,則伸烷基氧化物衍生物會變得難溶於水,而難以使用。 As shown in Table 4, although the alkylene oxide derivative represented by the formula (1) is obtained as a refining effect, in the total of the oxygen-extended ethyl group and the oxygen-extended alkyl group, the oxygen is extended. When the ratio of the alkyl group is small, the effect of miniaturization tends to be lowered. Further, if the above ratio becomes large, the alkylene oxide derivative becomes hardly soluble in water and is difficult to use.
因此,可認為在氧伸乙基與氧伸烷基之合計中,氧伸烷基所佔之比率較佳為20至80質量%,更進一步係以30至70質量%為更佳。 Therefore, it is considered that the ratio of the oxygen-extended alkyl group in the total of the oxygen-extended ethyl group and the oxygen-extended alkyl group is preferably from 20 to 80% by mass, more preferably from 30 to 70% by mass.
使用下述表5之配方,依照製法a製造O/W乳化組成物。在任一情形下,皆可得到乳化粒徑5μm以下之微細的O/W乳化組成物。 The O/W emulsified composition was produced in accordance with Process a using the formulation of Table 5 below. In either case, a fine O/W emulsified composition having an emulsified particle diameter of 5 μm or less can be obtained.
3.三仙膠(xanthan gum) 0.1 3. Sanxianghan (xanthan gum) 0.1
<油相> <oil phase>
(1)於室溫下混合第2水相(成分1至3),並使其溶解。 (1) The second aqueous phase (components 1 to 3) was mixed at room temperature and dissolved.
(2)於80至85℃使第1水相(成分4至9)溶解。 (2) The first aqueous phase (ingredients 4 to 9) was dissolved at 80 to 85 °C.
(3)於80至85℃使油相(成分10至15)溶解。 (3) The oil phase (ingredients 10 to 15) was dissolved at 80 to 85 °C.
(4)將第1水相及油相以均質機攪拌混合,調製乳化部分。 (4) The first aqueous phase and the oil phase were stirred and mixed by a homogenizer to prepare an emulsified portion.
(5)一邊以均質機攪拌乳化部分一邊添加第2水相並進行混合,得到O/W乳液。 (5) While stirring the emulsified portion with a homogenizer, the second aqueous phase was added and mixed to obtain an O/W emulsion.
實施例1中,乳化部分(成分4至15)中之成分9之濃度為5.8質量%,所得之乳液的黏度為3,770mPa.s/30℃,乳化粒徑為1 至5μm之範圍。 In Example 1, the concentration of the component 9 in the emulsified portion (components 4 to 15) was 5.8% by mass, and the viscosity of the obtained emulsion was 3,770 mPa. s/30 ° C, emulsified particle size is 1 To the range of 5 μm.
(1)於室溫下混合第2水相(成分1至9),並使其溶解。 (1) The second aqueous phase (components 1 to 9) was mixed at room temperature and dissolved.
(2)於80至85℃使第1水相(成分10至15)溶解。 (2) The first aqueous phase (components 10 to 15) is dissolved at 80 to 85 °C.
(3)於80至85℃使油相(成分16至21)溶解。 (3) The oil phase (ingredients 16 to 21) was dissolved at 80 to 85 °C.
(4)以均質機攪拌混合第1水相及油相,調製乳化部分。 (4) The first aqueous phase and the oil phase were mixed and stirred by a homogenizer to prepare an emulsified portion.
(5)一邊以均質機攪拌乳化部分一邊添加第2水相並進行混合,得到O/W乳液。 (5) While stirring the emulsified portion with a homogenizer, the second aqueous phase was added and mixed to obtain an O/W emulsion.
實施例2中,乳化部分(成分10至成分21)中之成分15的濃度為2.6質量%,所得之乳液之黏度為3,820mPa.s/30℃,乳化粒徑為1至5μm。 In Example 2, the concentration of the component 15 in the emulsified portion (component 10 to component 21) was 2.6% by mass, and the viscosity of the obtained emulsion was 3,820 mPa. The emulsified particle size is 1 to 5 μm at s/30 °C.
(1)於室溫下混合第2水相(成分1至8),並使其溶解。 (1) The second aqueous phase (components 1 to 8) was mixed at room temperature and dissolved.
(2)於80至85℃使第1水相(成分9至12)溶解。 (2) The first aqueous phase (ingredients 9 to 12) was dissolved at 80 to 85 °C.
(3)於80至85℃使油相(成分13至21)溶解。 (3) The oil phase (ingredients 13 to 21) was dissolved at 80 to 85 °C.
(4)將第1水相及油相以均質機攪拌混合,調製乳化部分。 (4) The first aqueous phase and the oil phase were stirred and mixed by a homogenizer to prepare an emulsified portion.
(5)一邊以均質機攪拌乳化部分一邊添加第2水相並進行混合,得到O/W乳液。 (5) While stirring the emulsified portion with a homogenizer, the second aqueous phase was added and mixed to obtain an O/W emulsion.
實施例3中,乳化部分(成分9至21)中之成分12的濃度為6.3質量%,所得之乳液之黏度為5,130mPa.s/30℃,乳化粒徑為1至5μm之範圍。 In Example 3, the concentration of the component 12 in the emulsified portion (ingredients 9 to 21) was 6.3% by mass, and the viscosity of the obtained emulsion was 5,130 mPa. The emulsified particle diameter is in the range of 1 to 5 μm at s/30 °C.
(1)於室溫下混合第2水相(成分1至9),並使其溶解。 (1) The second aqueous phase (components 1 to 9) was mixed at room temperature and dissolved.
(2)於80至85℃使第1水相(成分10至14)溶解。 (2) The first aqueous phase (components 10 to 14) is dissolved at 80 to 85 °C.
(3)於80至85℃使油相(成分15至21)溶解。 (3) The oil phase (ingredients 15 to 21) was dissolved at 80 to 85 °C.
(4)將第1水相及油相以均質機攪拌混合,調製乳化部分。 (4) The first aqueous phase and the oil phase were stirred and mixed by a homogenizer to prepare an emulsified portion.
(5)一邊以均質機攪拌乳化部分一邊添加第2水相並進行混合,得到O/W乳液。 (5) While stirring the emulsified portion with a homogenizer, the second aqueous phase was added and mixed to obtain an O/W emulsion.
實施例4中,乳化部分(成分10至21)中之成分14的濃度為4.4質量%,所得乳液之黏度為4,470mPa.s/30℃,乳化粒徑為1至5μm之範圍。 In Example 4, the concentration of the component 14 in the emulsified portion (components 10 to 21) was 4.4% by mass, and the viscosity of the obtained emulsion was 4,470 mPa. The emulsified particle diameter is in the range of 1 to 5 μm at s/30 °C.
Claims (4)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011232643 | 2011-10-24 | ||
JP2011239954 | 2011-11-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW201318642A true TW201318642A (en) | 2013-05-16 |
Family
ID=48167550
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW101135479A TW201318642A (en) | 2011-10-24 | 2012-09-27 | Method for producing O/W emulsified composition |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP5209816B1 (en) |
TW (1) | TW201318642A (en) |
WO (1) | WO2013061712A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106604714A (en) * | 2014-06-13 | 2017-04-26 | 株式会社资生堂 | alpha-gel-intermediate composition, and production method for alpha-gel-containing O/W emulsion cosmetic using said composition |
CN110049753A (en) * | 2016-12-16 | 2019-07-23 | 株式会社资生堂 | Oil-in-water type composition |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102345066B1 (en) * | 2014-04-21 | 2021-12-30 | 라이온 가부시키가이샤 | Liquid composition for oral use and method for improving resilience to freezing thereof |
JP6586854B2 (en) * | 2014-11-11 | 2019-10-09 | 東洋紡株式会社 | Emulsified composition |
JP2016124794A (en) * | 2014-12-26 | 2016-07-11 | ポーラ化成工業株式会社 | W/o/w emulsion composition |
US10660838B2 (en) | 2017-06-23 | 2020-05-26 | The Procter & Gamble Company | Composition and method for improving the appearance of skin |
JP7210462B2 (en) * | 2017-09-29 | 2023-01-23 | 株式会社 資生堂 | Oil-in-water emulsified cosmetic using ultrafine emulsion |
CN112165929A (en) * | 2018-06-06 | 2021-01-01 | 株式会社资生堂 | Oil-in-water type emulsion cosmetic using partially crosslinked or crosslinked dimethylpolysiloxane |
WO2019244500A1 (en) * | 2018-06-20 | 2019-12-26 | 株式会社 資生堂 | Oil-in-water type emulsion composition and production method therefor |
KR20210011964A (en) | 2018-07-03 | 2021-02-02 | 더 프록터 앤드 갬블 캄파니 | How to treat a skin condition |
JP6754871B2 (en) * | 2019-06-25 | 2020-09-16 | ポーラ化成工業株式会社 | W / O / W type emulsified composition |
DE102019212327A1 (en) * | 2019-08-19 | 2021-02-25 | Beiersdorf Ag | Cosmetic O / W emulsion with succinoglucan |
US10959933B1 (en) | 2020-06-01 | 2021-03-30 | The Procter & Gamble Company | Low pH skin care composition and methods of using the same |
WO2021247496A1 (en) | 2020-06-01 | 2021-12-09 | The Procter & Gamble Company | Method of improving penetration of a vitamin b3 compound into skin |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61153134A (en) * | 1984-12-27 | 1986-07-11 | Lion Corp | Manufacture of oil-in-water type emulsion |
JP3829048B2 (en) * | 2000-06-05 | 2006-10-04 | 株式会社資生堂 | Oil-in-water emulsion composition |
JP4731109B2 (en) * | 2003-10-31 | 2011-07-20 | 株式会社 資生堂 | Gel composition and cream composition using the same |
JP4968774B2 (en) * | 2006-08-11 | 2012-07-04 | 株式会社 資生堂 | Cream composition |
JP4709320B2 (en) * | 2009-09-04 | 2011-06-22 | 株式会社資生堂 | Method for producing O / W emulsion composition |
-
2012
- 2012-09-18 WO PCT/JP2012/073830 patent/WO2013061712A1/en active Application Filing
- 2012-09-18 JP JP2012204216A patent/JP5209816B1/en active Active
- 2012-09-27 TW TW101135479A patent/TW201318642A/en unknown
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106604714A (en) * | 2014-06-13 | 2017-04-26 | 株式会社资生堂 | alpha-gel-intermediate composition, and production method for alpha-gel-containing O/W emulsion cosmetic using said composition |
TWI593428B (en) * | 2014-06-13 | 2017-08-01 | 資生堂股份有限公司 | Alpha gel intermediae composition, and manufacturing method for o/w emulsion cosmetic containing the alpha gel by using the composition |
CN110049753A (en) * | 2016-12-16 | 2019-07-23 | 株式会社资生堂 | Oil-in-water type composition |
TWI771348B (en) * | 2016-12-16 | 2022-07-21 | 日商資生堂股份有限公司 | Oil-in-water composition |
Also Published As
Publication number | Publication date |
---|---|
JP2013116884A (en) | 2013-06-13 |
JP5209816B1 (en) | 2013-06-12 |
WO2013061712A1 (en) | 2013-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW201318642A (en) | Method for producing O/W emulsified composition | |
EP2474296B2 (en) | Method for producing o/w emulsion composition | |
US20120164094A1 (en) | Production Method Of High-Viscosity O/W Cream | |
KR101159574B1 (en) | External preparation for skin | |
US20110274731A1 (en) | Production Method Of Fine O/W Emulsion External Preparation | |
JP5244989B2 (en) | Method for producing O / W emulsion composition | |
KR20180054641A (en) | Microemulsive cosmetic materials and manufacturing method thereof | |
KR101861659B1 (en) | Manufacturing method of water-in-oil type emulsion cosmetic composition | |
JP2008230994A (en) | Cosmetic | |
JP5243078B2 (en) | Highly polar oil-containing oil-in-water ultrafine emulsion external preparation and method for producing the oil-in-water ultrafine emulsion external preparation | |
JP5117208B2 (en) | Highly polar oil-containing oil-in-water ultrafine emulsion external preparation and method for producing the oil-in-water ultrafine emulsion external preparation | |
JP6506755B2 (en) | Foamable personal care composition comprising a continuous oil phase | |
BR112020002821A2 (en) | emulsifying system, personal care product, method and use | |
JP3766017B2 (en) | Powder-containing emulsion | |
JP2010209018A (en) | Nonionic surfactant composition, and cosmetic and external preparation using the same | |
JP7301826B2 (en) | Compounds suitable for personal care and cosmetic applications | |
JP2007269668A (en) | Oil-in-water whitening cosmetic | |
JPH10101522A (en) | Emulsified composition | |
JP2007269670A (en) | Oil-in-water moisturizing cosmetic |